Correlation Between Biotech Growth and P10

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotech Growth and P10 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotech Growth and P10 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Biotech Growth and P10 Inc, you can compare the effects of market volatilities on Biotech Growth and P10 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotech Growth with a short position of P10. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotech Growth and P10.

Diversification Opportunities for Biotech Growth and P10

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Biotech and P10 is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding The Biotech Growth and P10 Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on P10 Inc and Biotech Growth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Biotech Growth are associated (or correlated) with P10. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of P10 Inc has no effect on the direction of Biotech Growth i.e., Biotech Growth and P10 go up and down completely randomly.

Pair Corralation between Biotech Growth and P10

Assuming the 90 days trading horizon The Biotech Growth is expected to generate 0.85 times more return on investment than P10. However, The Biotech Growth is 1.18 times less risky than P10. It trades about 0.23 of its potential returns per unit of risk. P10 Inc is currently generating about -0.12 per unit of risk. If you would invest  93,600  in The Biotech Growth on September 11, 2025 and sell it today you would earn a total of  27,400  from holding The Biotech Growth or generate 29.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

The Biotech Growth  vs.  P10 Inc

 Performance 
       Timeline  
Biotech Growth 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in The Biotech Growth are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Biotech Growth unveiled solid returns over the last few months and may actually be approaching a breakup point.
P10 Inc 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days P10 Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors.

Biotech Growth and P10 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotech Growth and P10

The main advantage of trading using opposite Biotech Growth and P10 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotech Growth position performs unexpectedly, P10 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in P10 will offset losses from the drop in P10's long position.
The idea behind The Biotech Growth and P10 Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk